Kidney cancer, Renal cell cancer, Secondary cancers
Results
Phase 2
This trial compared apitolisib and everolimus for kidney cancer that had spread to another part of the body. It was for people with renal cell cancer (RCC).
The trial was open for people to join between 2011 and 2012. The team published the results in 2016.
Recruitment start: 1 October 2011
Recruitment end: 30 July 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Thomas Powles
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche-Genentech
Last reviewed: 6 July 2023
CRUK internal database number: 8876
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
